Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary

Saved in:
Bibliographic Details
Published in:BJU international 2023-05, Vol.131 (5), p.566-568
Main Authors: Klatte, Tobias, Welsh, Sarah J., Riddick, Antony C. P., Karam, José A., Stewart, Grant D.
Format: Article
Language:English
Subjects:
Carcinoma, Renal Cell - surgery
cava thrombus
Humans
Kidney cancer
Kidney Neoplasms - surgery
neoadjuvant
Neoplastic Cells, Circulating - pathology
Nephrectomy
Renal cell carcinoma
Retrospective Studies
systemic treatment
Thrombectomy
Thrombosis
thrombus
Tumors
tyrosine kinase inhibitor
Tyrosine Kinase Inhibitors
Vena Cava, Inferior - pathology
Venous Thrombosis - drug therapy
Venous Thrombosis - surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503
cites cdi_FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503
container_end_page 568
container_issue 5
container_start_page 566
container_title BJU international
container_volume 131
creator Klatte, Tobias
Welsh, Sarah J.
Riddick, Antony C. P.
Karam, José A.
Stewart, Grant D.
description
doi_str_mv 10.1111/bju.15966
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2765775659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2804124022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503</originalsourceid><addsrcrecordid>eNp1kUtPAjEUhRujEUQX_gHTxI0ugHY67cy4U-IzJG4gcTfpDG0oMjPQB4TEH-9FwIWJXdz2tl9Pcu5B6JKSHoXVL2ahR3kmxBFq01jE3ZiSj-PDmWSihc6cmxECF4KfohYTgqUkTtvoa7SxjTO1wp-mlk5hU09NYXxjsbdK-krVHmvorKrlHJdqDkXa0tRNJfHa-Cn80MoaQFaAwONKYh-qJoDC1DZVEdwdlngZZO2Nl96sFHahqqTdnKMTLedOXez3Dho_PY4GL93h-_Pr4H7YLVmaim6ZplnBFc1EknCelIQkMtl6kbFOUyZkWRRMZyzSjEdiwihJokLqWIsJIREnrINudroL2yyDcj6vjNtakbVqgsujRHCQFjwD9PoPOgMnYB0omBiNYhJFQN3uqBKG56zS-cKaraOcknwbSQ6R5D-RAHu1VwxFpSa_5CEDAPo7YG3mavO_Uv7wNt5JfgN1h5aK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2804124022</pqid></control><display><type>article</type><title>Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Klatte, Tobias ; Welsh, Sarah J. ; Riddick, Antony C. P. ; Karam, José A. ; Stewart, Grant D.</creator><creatorcontrib>Klatte, Tobias ; Welsh, Sarah J. ; Riddick, Antony C. P. ; Karam, José A. ; Stewart, Grant D.</creatorcontrib><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/bju.15966</identifier><identifier>PMID: 36638048</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Carcinoma, Renal Cell - surgery ; cava thrombus ; Humans ; Kidney cancer ; Kidney Neoplasms - surgery ; neoadjuvant ; Neoplastic Cells, Circulating - pathology ; Nephrectomy ; Renal cell carcinoma ; Retrospective Studies ; systemic treatment ; Thrombectomy ; Thrombosis ; thrombus ; Tumors ; tyrosine kinase inhibitor ; Tyrosine Kinase Inhibitors ; Vena Cava, Inferior - pathology ; Venous Thrombosis - drug therapy ; Venous Thrombosis - surgery</subject><ispartof>BJU international, 2023-05, Vol.131 (5), p.566-568</ispartof><rights>2023 The Authors. BJU International published by John Wiley &amp; Sons Ltd on behalf of BJU International.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503</citedby><cites>FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503</cites><orcidid>0000-0003-3188-9140 ; 0000-0001-7697-9591 ; 0000-0002-4392-6861</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36638048$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Klatte, Tobias</creatorcontrib><creatorcontrib>Welsh, Sarah J.</creatorcontrib><creatorcontrib>Riddick, Antony C. P.</creatorcontrib><creatorcontrib>Karam, José A.</creatorcontrib><creatorcontrib>Stewart, Grant D.</creatorcontrib><title>Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary</title><title>BJU international</title><addtitle>BJU Int</addtitle><subject>Carcinoma, Renal Cell - surgery</subject><subject>cava thrombus</subject><subject>Humans</subject><subject>Kidney cancer</subject><subject>Kidney Neoplasms - surgery</subject><subject>neoadjuvant</subject><subject>Neoplastic Cells, Circulating - pathology</subject><subject>Nephrectomy</subject><subject>Renal cell carcinoma</subject><subject>Retrospective Studies</subject><subject>systemic treatment</subject><subject>Thrombectomy</subject><subject>Thrombosis</subject><subject>thrombus</subject><subject>Tumors</subject><subject>tyrosine kinase inhibitor</subject><subject>Tyrosine Kinase Inhibitors</subject><subject>Vena Cava, Inferior - pathology</subject><subject>Venous Thrombosis - drug therapy</subject><subject>Venous Thrombosis - surgery</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp1kUtPAjEUhRujEUQX_gHTxI0ugHY67cy4U-IzJG4gcTfpDG0oMjPQB4TEH-9FwIWJXdz2tl9Pcu5B6JKSHoXVL2ahR3kmxBFq01jE3ZiSj-PDmWSihc6cmxECF4KfohYTgqUkTtvoa7SxjTO1wp-mlk5hU09NYXxjsbdK-krVHmvorKrlHJdqDkXa0tRNJfHa-Cn80MoaQFaAwONKYh-qJoDC1DZVEdwdlngZZO2Nl96sFHahqqTdnKMTLedOXez3Dho_PY4GL93h-_Pr4H7YLVmaim6ZplnBFc1EknCelIQkMtl6kbFOUyZkWRRMZyzSjEdiwihJokLqWIsJIREnrINudroL2yyDcj6vjNtakbVqgsujRHCQFjwD9PoPOgMnYB0omBiNYhJFQN3uqBKG56zS-cKaraOcknwbSQ6R5D-RAHu1VwxFpSa_5CEDAPo7YG3mavO_Uv7wNt5JfgN1h5aK</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Klatte, Tobias</creator><creator>Welsh, Sarah J.</creator><creator>Riddick, Antony C. P.</creator><creator>Karam, José A.</creator><creator>Stewart, Grant D.</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3188-9140</orcidid><orcidid>https://orcid.org/0000-0001-7697-9591</orcidid><orcidid>https://orcid.org/0000-0002-4392-6861</orcidid></search><sort><creationdate>202305</creationdate><title>Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary</title><author>Klatte, Tobias ; Welsh, Sarah J. ; Riddick, Antony C. P. ; Karam, José A. ; Stewart, Grant D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Carcinoma, Renal Cell - surgery</topic><topic>cava thrombus</topic><topic>Humans</topic><topic>Kidney cancer</topic><topic>Kidney Neoplasms - surgery</topic><topic>neoadjuvant</topic><topic>Neoplastic Cells, Circulating - pathology</topic><topic>Nephrectomy</topic><topic>Renal cell carcinoma</topic><topic>Retrospective Studies</topic><topic>systemic treatment</topic><topic>Thrombectomy</topic><topic>Thrombosis</topic><topic>thrombus</topic><topic>Tumors</topic><topic>tyrosine kinase inhibitor</topic><topic>Tyrosine Kinase Inhibitors</topic><topic>Vena Cava, Inferior - pathology</topic><topic>Venous Thrombosis - drug therapy</topic><topic>Venous Thrombosis - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Klatte, Tobias</creatorcontrib><creatorcontrib>Welsh, Sarah J.</creatorcontrib><creatorcontrib>Riddick, Antony C. P.</creatorcontrib><creatorcontrib>Karam, José A.</creatorcontrib><creatorcontrib>Stewart, Grant D.</creatorcontrib><collection>Wiley Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Klatte, Tobias</au><au>Welsh, Sarah J.</au><au>Riddick, Antony C. P.</au><au>Karam, José A.</au><au>Stewart, Grant D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2023-05</date><risdate>2023</risdate><volume>131</volume><issue>5</issue><spage>566</spage><epage>568</epage><pages>566-568</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36638048</pmid><doi>10.1111/bju.15966</doi><tpages>570</tpages><orcidid>https://orcid.org/0000-0003-3188-9140</orcidid><orcidid>https://orcid.org/0000-0001-7697-9591</orcidid><orcidid>https://orcid.org/0000-0002-4392-6861</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1464-4096
ispartof BJU international, 2023-05, Vol.131 (5), p.566-568
issn 1464-4096
1464-410X
language eng
recordid cdi_proquest_miscellaneous_2765775659
source Wiley-Blackwell Read & Publish Collection
subjects Carcinoma, Renal Cell - surgery
cava thrombus
Humans
Kidney cancer
Kidney Neoplasms - surgery
neoadjuvant
Neoplastic Cells, Circulating - pathology
Nephrectomy
Renal cell carcinoma
Retrospective Studies
systemic treatment
Thrombectomy
Thrombosis
thrombus
Tumors
tyrosine kinase inhibitor
Tyrosine Kinase Inhibitors
Vena Cava, Inferior - pathology
Venous Thrombosis - drug therapy
Venous Thrombosis - surgery
title Tyrosine kinase inhibitor treatment for renal cell carcinoma with inferior vena cava tumour thrombus: a quantitative summary
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A40%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tyrosine%20kinase%20inhibitor%20treatment%20for%20renal%20cell%20carcinoma%20with%20inferior%20vena%20cava%20tumour%20thrombus:%20a%20quantitative%20summary&rft.jtitle=BJU%20international&rft.au=Klatte,%20Tobias&rft.date=2023-05&rft.volume=131&rft.issue=5&rft.spage=566&rft.epage=568&rft.pages=566-568&rft.issn=1464-4096&rft.eissn=1464-410X&rft_id=info:doi/10.1111/bju.15966&rft_dat=%3Cproquest_cross%3E2804124022%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3886-c889b5e19677557c007a70146a4f8836acbb3f932f3526d31072baf4f6d002503%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2804124022&rft_id=info:pmid/36638048&rfr_iscdi=true